Severe cutaneous drug reactions in children

被引:0
|
作者
Mockenhaupt, Maja [1 ,2 ]
机构
[1] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Freiburg, Germany
[2] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Hauptstr 7, D-79104 Freiburg, Germany
关键词
Epidermal necrolysis; Drug reaction with eosinophilia and systemic symptoms; Anticonvulsants; Sulfonamides; Sulfasalazine; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; SYSTEMIC SYMPTOMS; MULTIFORME MAJUS; DRESS; EPIDEMIOLOGY; SCORTEN;
D O I
10.1007/s00112-023-01753-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are considered as one disease entity with different degrees of severity and are also referred to as "epidermal" or "epithelial necrolysis" (EN). The group of drug reactions with primarily systemic alterations is represented by a condition known as drug reaction with eosinophilia and systemic symptoms (DRESS). Although EN is generally considered as a drug reaction, a causative agent can only be identified in about 50% of all pediatric cases. Once a clear diagnosis is established, specific treatment measures should be carried out, whereby discontinuation of the causative agent plays a decisive role in drug-induced cases. In order to be able to identify and discontinue the drug responsible, a detailed medication history must be obtained. Certain antiepileptic drugs, sulfonamides and sulfasalazine are among the most frequent triggers of EN and DRESS in children. Supportive therapy including appropriate topical treatment, pain management and ophthalmological consultations are of utmost importance in EN but a short-term immunomodulating treatment with cyclosporine A has been shown to be helpful. In contrast, in DRESS middle to long-term systemic treatment with glucocorticosteroids is recommended.
引用
收藏
页码:439 / 451
页数:13
相关论文
共 50 条
  • [41] Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
    Miyagawa, Fumi
    Asada, Hideo
    BIOMOLECULES, 2021, 11 (06)
  • [42] Bronchopulmonary involvement in severe cutaneous adverse reactions
    de Prost, N.
    Mekontso-Dessap, A.
    Valeyrie-Allanore, L.
    Maitre, B.
    REANIMATION, 2013, 22 (01): : 73 - 79
  • [43] Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
    Sasidharanpillai, Sarita
    Riyaz, Najeeba
    Khader, Anza
    Rajan, Uma
    Binitha, Manikoth P.
    Sureshan, Deepthi N.
    INDIAN JOURNAL OF DERMATOLOGY, 2015, 60 (01) : 102
  • [44] Management of severe cutaneous adverse drug reactions to corticosteroids
    Waton, J.
    Baeck, M.
    Torres, M.
    Barbaud, A.
    REVUE FRANCAISE D ALLERGOLOGIE, 2013, 53 (03): : 298 - 303
  • [45] Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study
    Javdan, Bahar
    Marwaha, Siddharth
    Wassef, Cindy
    Pappert, Amy
    Horton, Daniel B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (12)
  • [46] Severe cutaneous adverse reactions
    Hung, Shuen-Iu
    Mockenhaupt, Maja
    Blumenthal, Kimberly G.
    Abe, Riichiro
    Ueta, Mayumi
    Ingen-Housz-Oro, Saskia
    Phillips, Elizabeth J.
    Chung, Wen-Hung
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01)
  • [47] Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
    Scavone, Cristina
    Di Mauro, Cristina
    Ruggiero, Rosanna
    Bernardi, Francesca Futura
    Trama, Ugo
    Aiezza, Maria Luisa
    Rafaniello, Concetta
    Capuano, Annalisa
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (01) : 41 - 51
  • [48] A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
    Kloypan, Chiraphat
    Koomdee, Napatrupron
    Satapornpong, Patompong
    Tempark, Therdpong
    Biswas, Mohitosh
    Sukasem, Chonlaphat
    PHARMACEUTICALS, 2021, 14 (11)
  • [49] The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse Reactions
    Dodiuk-Gad, Roni P.
    Chung, Wen-Hung
    Yang, Chih-Hsun
    Lu, Chun-Wei
    Hui, Rosaline Chung-Yee
    Shear, Neil H.
    DRUG SAFETY, 2014, 37 (06) : 459 - 464
  • [50] An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese
    Jiang, Menglin
    Yang, Jin
    Yang, Linlin
    Wang, Lina
    Wang, Ting
    Han, Shengna
    Cheng, Ye
    Chen, Zihua
    Su, Yu
    Zhang, Lirong
    Yang, Fanping
    Chen, Sheng-an
    Zhang, Jin
    Xiong, Hao
    Wang, Lanting
    Zhang, Zhen
    Ma, Li
    Luo, Xiaoqun
    Xing, Qinghe
    ISCIENCE, 2023, 26 (08)